Tonix Pharmaceuticals Holding Corp. - Common Stock — 현금 흐름 (NASDAQ:TNXP)

Financials

영업활동으로 인한 현금 -48.57 M-75.56 M-98.05 M-102 M-60.92 M-99.84 M -125.58 M 투자 활동으로 인한 현금 -8.56 M-35.31 M-48.15 M-29.07 M-120 K-4.53 M -6.21 M 재무활동으로 인한 현금 123.11 M212.49 M87.84 M36.52 M134.87 M214.53 M 185.2 M 잉여 현금 흐름 -48.57 M-75.56 M-98.05 M-102 M-60.92 M-103.21 M -130.64 M

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

TNXP

Financials

Tonix Pharmaceuticals Holding Corp. - Common Stock

뉴스

Tonix Pharmaceuticals Holding Corp. (TNXP) Presents at BIO-Europe Spring 2026 - Slideshow (NASDAQ:TNXP) 2026-03-25

Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch - Tonix Pharmaceuticals (NASDAQ:TNXP)

Tonix Pharma Q1 실적 에상치보다 저조, 수익 예상치를 넘어

Tonix Pharma earnings missed by $0.79, revenue topped estimates

토닉스, 섬유근통증 약물 데이터 폴란드 학회서 발표

Tonix presents fibromyalgia drug data at Poland conference

Tonix Pharmaceuticals, 나스닥 글로벌 셀렉트 시장으로 이전

Tonix Pharmaceuticals moves to Nasdaq Global Select Market

Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting - Tonix Pharmaceuticals (NASDAQ:TNXP)

Tonix Pharma, 섬유근통 치료제 임상서 유의미한 통증 감소 효과

Tonix’s fibromyalgia drug shows significant pain reduction in study

Tonix Pharmaceuticals secures $20 million investment from Point72